These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 38365953)
1. Glycerol kinase enzyme is a prognostic predictor in esophageal carcinoma and is associated with immune cell infiltration. Ying F; Chen X; Lv L Sci Rep; 2024 Feb; 14(1):3922. PubMed ID: 38365953 [TBL] [Abstract][Full Text] [Related]
2. Bridging Integrator 3 (BIN3) Downregulation Predicts a Poor Prognosis in Patients with Esophagus Carcinoma: A Study based on TCGA Data. Li D; Deng W; Huang G; Xiao X Comb Chem High Throughput Screen; 2023; 26(11):1974-1989. PubMed ID: 36475339 [TBL] [Abstract][Full Text] [Related]
3. APOC1 predicts a worse prognosis for esophageal squamous cell carcinoma and is associated with tumor immune infiltration during tumorigenesis. Cao X; Wu B; Guo S; Zhong W; Zhu S; Zhang Z; Gu L; Li H Pathol Oncol Res; 2023; 29():1610976. PubMed ID: 36969562 [No Abstract] [Full Text] [Related]
4. Identification and validation of UBE2B as a prognostic biomarker promoting the development of esophageal carcinomas. Ding H; Xu JC; Ding ZG; Wu LF; Liu YB; Zhang YF; Chen TY; Zhang YQ; Zhou PH Front Immunol; 2024; 15():1295305. PubMed ID: 38481990 [TBL] [Abstract][Full Text] [Related]
5. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma. Hao YP; Wang WY; Qiao Q; Li G Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884 [TBL] [Abstract][Full Text] [Related]
6. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma. Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882 [TBL] [Abstract][Full Text] [Related]
7. Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma: prognostic implications and potential for personalized therapies. Yu XW; She PW; Chen FC; Chen YY; Zhou S; Wang XM; Lin XR; Liu QL; Huang ZJ; Qiu Y BMC Cancer; 2024 Feb; 24(1):230. PubMed ID: 38373930 [TBL] [Abstract][Full Text] [Related]
8. Systematic investigation of the clinical significance and prognostic value of the CBXs in esophageal cancer. Hou J; Yang Y; Gao H; Ouyang T; Liu Q; Ding R; Kan H Medicine (Baltimore); 2022 Oct; 101(40):e30888. PubMed ID: 36221371 [TBL] [Abstract][Full Text] [Related]
9. COX7B Is a New Prognostic Biomarker and Correlates with Tumor Immunity in Esophageal Carcinoma. Song Y; Gao N; Yang Z; Zhang S; Fan T; Zhang B Mediators Inflamm; 2023; 2023():6831695. PubMed ID: 37273454 [TBL] [Abstract][Full Text] [Related]
10. Identification and validation of DPY30 as a prognostic biomarker and tumor immune microenvironment infiltration characterization in esophageal cancer. Mei PY; Xiao H; Guo Q; Meng WY; Wang ML; Huang QF; Liao YD Oncol Lett; 2023 Feb; 25(2):68. PubMed ID: 36644145 [TBL] [Abstract][Full Text] [Related]
11. eIF6 is potential diagnostic and prognostic biomarker that associated with Gao Y; Yuan L; Zeng J; Li F; Li X; Tan F; Liu X; Wan H; Kui X; Liu X; Ke C; Pei Z J Transl Med; 2022 Jul; 20(1):303. PubMed ID: 35794622 [TBL] [Abstract][Full Text] [Related]
12. High expression of caspase-8 as a predictive factor of poor prognosis in patients with esophageal cancer. Chai J; Lei Y; Xiang X; Ye J; Zhao H; Yi L Cancer Med; 2023 Mar; 12(6):7651-7666. PubMed ID: 36533709 [TBL] [Abstract][Full Text] [Related]
13. A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma. Wu K; Zhang C; Zhang C; Dai D Biomed Res Int; 2020; 2020():5973082. PubMed ID: 32104700 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the Immune Infiltration Landscape and Identification of Prognostic Biomarkers for Esophageal Cancer. Chen Y; Huang X; Chen L; Weng G; Huang Z; Zhang Y; Xiao T; Chen J; Zhu K; Xu Y Mol Biotechnol; 2023 Mar; 65(3):361-383. PubMed ID: 35780460 [TBL] [Abstract][Full Text] [Related]
15. The prognostic value of an immune-related gene signature and infiltrating tumor immune cells based on bioinformatics analysis in primary esophageal cancer. Du H; Pang S; Li Y; Zhu L; Hang J; Chen L J Gastrointest Oncol; 2022 Aug; 13(4):1556-1570. PubMed ID: 36092327 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Values and Underlying Regulatory Network of Cohesin Subunits in Esophageal Carcinoma. Gan W; Wang W; Li T; Zhang R; Hou Y; Lv S; Zeng Z; Yan Z; Yang M J Cancer; 2022; 13(5):1588-1602. PubMed ID: 35371307 [No Abstract] [Full Text] [Related]
17. Identification of Autophagy-Related Genes and Small-Molecule Drugs in Esophageal Carcinoma. Li Z; Dong K; Guo P; Tan Z; Zhang F; Tian Y; Lv H Med Sci Monit; 2020 May; 26():e921855. PubMed ID: 32415055 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of ZNF family genes in prognosis, immunity, and treatment of esophageal cancer. Hong K; Yang Q; Yin H; Wei N; Wang W; Yu B BMC Cancer; 2023 Apr; 23(1):301. PubMed ID: 37013470 [TBL] [Abstract][Full Text] [Related]
19. Multi-Omics Analysis Reveals the IFI6 Gene as a Prognostic Indicator and Therapeutic Target in Esophageal Cancer. Viet-Nhi NK; Minh Quan T; Cong Truc V; Anh Bich T; Hoang Nam P; Le NQK; Chen PY; Hung SH Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473938 [TBL] [Abstract][Full Text] [Related]
20. Identification of hub necroptosis-related lncRNAs for prognosis prediction of esophageal carcinoma. Luo Z; Ding E; Yu L; Wang W; Guo Q; Li X; Wang Y; Li T; Zhang Y; Zhang X Aging (Albany NY); 2023 Jun; 15(11):4794-4819. PubMed ID: 37263709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]